Most guidelines flag an estimated glomerular filtration rate (eGFR) below 15 mL/min/1.73 m² as the point where dialysis should be evaluated, but the number alone rarely drives the decision. That threshold marks stage 5 chronic kidney disease (CKD), the most advanced stage, yet many people at that level feel well enough to wait, while others with slightly higher readings develop symptoms that demand immediate action. The real answer involves symptoms, lab trends, nutrition, and how fast your kidneys are declining, all weighed alongside your age and other health conditions.
The eGFR Number That Opens the Conversation
The Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines recommend that doctors evaluate the benefits and risks of starting dialysis once a patient reaches stage 5, defined as an eGFR below 15 mL/min/1.73 m². Even the guidelines themselves note that the ideal time to begin remains debated.1PubMed Central. When should commence dialysis: focusing on the predialysis condition In practice, many nephrologists use this cutoff as a planning trigger rather than a hard start line. Once your eGFR dips below 15, your care team will typically begin active discussions about dialysis modality, vascular access, and timing, but “below 15” does not automatically mean “start tomorrow.”
It is worth knowing that eGFR is an estimate, not a direct measurement. The most common formula uses a blood test called creatinine, but creatinine levels can be thrown off by muscle mass, diet, and medications. Cystatin C, an alternative blood marker, correlates strongly with creatinine-based estimates and can serve as a reliable backup when creatinine readings are unreliable.2PubMed Central. Cystatin C vs creatinine eGFR in advanced CKD: an analysis of the STOP-ACEi trial The point is that doctors rarely hang the dialysis decision on a single lab value. They look at trends over weeks or months, cross-check with other markers, and weigh the clinical picture alongside the number.
Why Symptoms Matter More Than the Number
Two people can have an eGFR of 12 and feel entirely different. One might be eating normally, sleeping well, and functioning at work. The other might be dealing with severe nausea, mental fogginess, itching, fatigue, and poor appetite. Dialysis initiation can variably affect quality of life and the relief of these uremic symptoms, which include anorexia, cognitive impairment, depressive symptoms, itching, and sleep problems.3PubMed Central. Symptom Management of the Patient with CKD: The Role of Dialysis That variability is exactly why nephrologists treat symptoms as a stronger signal than the eGFR number in isolation.
A common pattern is that the kidney team monitors you closely once your eGFR falls below about 20, checking in every one to three months. They watch for the constellation of uremic symptoms: persistent nausea or vomiting, a metallic taste that kills your appetite, swelling in the legs that does not respond well to diuretics, shortness of breath from fluid overload, difficulty concentrating, or unrelenting fatigue. When these symptoms start interfering with daily life and stop responding to dietary changes and medications, that is often the practical tipping point for dialysis.
Emergency Triggers for Immediate Dialysis
Sometimes the question is not “when should we start?” but “we need to start right now.” Acute kidney injury or a sudden worsening of chronic disease can create life-threatening situations that require emergency dialysis regardless of what your baseline eGFR was. Clinicians use a set of criteria sometimes abbreviated as AEIOU: severe acidosis, dangerous electrolyte imbalances (particularly high potassium), certain poisonings or intoxications, fluid overload that threatens breathing, and severe uremia with symptoms like seizures or pericarditis.4Wits Journal of Clinical Medicine. Predictors of six-month mortality after emergency haemodialysis for acute kidney injury in adults living with HIV: a retrospective cohort study
These emergencies can arise in people who have never been told they have kidney disease. Someone might show up in an emergency department with a potassium level high enough to cause a cardiac arrest, and dialysis begins within hours. In the chronic kidney disease trajectory, though, emergency starts are ideally avoided because they carry worse outcomes. One study found that patients who began hemodialysis urgently without prior follow-up had the lowest two-year survival rates, with older patients starting emergently through a temporary catheter faring worst of all.5PubMed. Effect of emergency start and central venous catheter on outcomes in incident hemodialysis patients: a prospective observational cohort This is a major reason nephrologists push for early planning even when dialysis itself might be months or years away.
The Early-Versus-Late Debate
For years, there was a strong push in nephrology to start dialysis earlier, when eGFR was still in the 10-to-14 range rather than waiting until it dropped below 7 or 8. The logic seemed sound: intervene before the patient deteriorates. Then a landmark randomized trial compared early initiation (target eGFR of 10 to 14) against late initiation (target eGFR of 5 to 7). Over a median follow-up of about three and a half years, roughly the same proportion of patients died in each group, with no meaningful difference in cardiovascular events, infections, or dialysis complications.6PubMed. A randomized, controlled trial of early versus late initiation of dialysis
That trial, known as IDEAL, fundamentally changed how nephrologists think about timing. The results showed that using eGFR alone as a trigger to start dialysis did not improve survival or other outcomes that matter to patients.7PubMed Central. Timing of Dialysis Initiation: What Has Changed Since IDEAL? The takeaway was not that timing does not matter at all, but that the eGFR number by itself is a poor guide. A symptom-driven approach, starting dialysis when the patient actually needs it rather than when the lab value crosses an arbitrary line, is now the dominant philosophy.
There is also a biological reason that starting too early could be counterproductive. Your remaining kidney function, even at very low levels, provides benefits that dialysis cannot fully replicate. Over half of that residual function can be lost in just the first five months of hemodialysis treatment.8Archives of Internal Medicine. Early Start of Hemodialysis May Be Harmful Every month you can safely delay dialysis while preserving the kidney function you still have is a month where your own kidneys are contributing to fluid balance, toxin removal, and hormone production in ways that a machine cannot perfectly mimic.
How Age and Frailty Change the Calculus
The standard framework assumes that a patient will eventually need and benefit from dialysis. For older adults, especially those with multiple chronic conditions or significant frailty, that assumption deserves scrutiny. Across studies comparing dialysis to conservative kidney management in older patients, dialysis prolonged survival mainly in younger and less frail individuals. In patients with high levels of frailty and multiple other illnesses, conservative management offered comparable or even better quality of life and fewer hospitalizations.9PubMed Central. Dialysis versus conservative kidney management in older adults: why one size does not fit all
Conservative kidney management does not mean doing nothing. It involves aggressive symptom control, dietary management, fluid restriction, medications to handle complications like anemia and bone disease, and palliative care when appropriate. For someone in their eighties with advanced heart failure and dementia, the physical demands of hemodialysis three times a week, including the travel, the drops in blood pressure during treatment, and the post-treatment exhaustion, can outweigh any survival benefit. Having an honest conversation with a nephrologist about whether dialysis would actually improve your life is as important as knowing the eGFR threshold that triggers the conversation in the first place.
Shared decision-making tools are being developed to help with exactly this situation. A randomized trial tested an intervention designed to help older patients with advanced CKD clarify their treatment preferences. At baseline, more than half of patients were unsure what they wanted. Over the following months, the structured decision support substantially reduced that uncertainty compared to usual care.10PubMed. Effectiveness of an Intervention to Improve Decision Making for Older Patients With Advanced Chronic Kidney Disease: A Randomized Controlled Trial The research reflects a growing recognition in nephrology that the question is not just “when” to start dialysis but “whether” it is the right choice for a given person.
Does It Matter Whether You Have Diabetes?
Since diabetes is the leading cause of kidney failure worldwide, a natural question is whether people with diabetes should start dialysis at a different eGFR than people without it. The answer appears to be no. A systematic review that specifically examined whether diabetes changed the optimal timing of dialysis initiation found no difference. A randomized trial included in that review showed no interaction between diabetes status and the effect of early versus late initiation on mortality.11PubMed. Timing of start of dialysis in diabetes mellitus patients: a systematic literature review The symptom-driven approach applies equally whether your kidney disease stems from diabetes, high blood pressure, autoimmune conditions, or anything else.
The Peritoneal Dialysis Versus Hemodialysis Difference
There is an interesting wrinkle depending on which type of dialysis you choose. People who start peritoneal dialysis (PD), the kind done at home through the abdomen, tend to begin at a slightly lower eGFR than those who start hemodialysis (HD). One study found that PD starters had a mean eGFR of about 7.8 at initiation compared to about 9.9 for HD starters. HD starters also showed a steeper decline in kidney function in the months leading up to dialysis.12PubMed. Transition Period Clinical Trajectories for PD Versus HD Starters This may reflect the fact that PD preserves residual kidney function somewhat better than HD in the early period, making doctors more comfortable allowing PD patients to start a bit later.
PD also lends itself well to an incremental approach. Instead of jumping straight into full-dose dialysis, you start with fewer exchanges or shorter treatment times, letting your remaining kidney function do part of the work. This strategy has been associated with better preservation of residual kidney function compared to starting full-dose treatment immediately.13PubMed Central. Incremental dialysis for preserving residual kidney function-Does one size fit all when initiating dialysis? A systematic review and meta-analysis suggested that incremental dialysis may also improve survival compared to full-dose dialysis, though the authors cautioned that the available evidence was limited.14Journal of Nephrology. Incremental dialysis in ESRD: systematic review and meta-analysis Incremental hemodialysis, starting with twice-a-week instead of three-times-a-week sessions, is also gaining traction, though it requires careful monitoring to make sure you are getting adequate clearance.
Planning Your Access Well Before You Need It
One of the most practical aspects of the “how low” question is that it directly affects when you should get vascular access surgery. If you are heading toward hemodialysis, you need a working fistula or graft, and these take time to mature. Guidelines generally recommend creating a fistula three to twelve months before the anticipated start of dialysis, but real-world data shows that timing is often off. One large study found that only about 40% of patients had their fistula created within that recommended window. Roughly 30% had theirs created within 90 days of starting dialysis, which is too late for many fistulas to mature, while another 30% had surgery more than a year in advance.15PubMed Central. Likelihood of starting dialysis after incident fistula creation
The challenge is prediction. How quickly your eGFR is falling makes a huge difference. A decision analysis found that for people whose kidney function declines rapidly, referral for fistula creation should happen when eGFR is around 25, whereas slower progressors can wait until eGFR is closer to 15 and achieve similarly good outcomes.16PubMed. Timing of arteriovenous fistula creation in patients With CKD: a decision analysis If you create a fistula too early, you might live for years without needing it, and the access can deteriorate. Too late, and you end up starting dialysis through a temporary catheter in your neck, which carries higher infection risk and worse outcomes. This is why your rate of eGFR decline, not just the current number, is so important for planning.
Medications That Push Dialysis Further Into the Future
The conversation about “how low” is incomplete without mentioning that the point at which you arrive at dialysis is increasingly something medicine can postpone. SGLT2 inhibitors, a class of medications originally developed for diabetes, have shown strong evidence of slowing kidney function decline and reducing the risk of progressing to kidney failure. A meta-analysis of large clinical trials demonstrated that these drugs delay CKD progression and reduce cardiovascular events regardless of whether the patient has diabetes.17Nephrology Dialysis Transplantation. SGLT2 inhibitors in CKD: are they really effective in all patients?
The evidence extends even to late-stage disease. A study looking specifically at people with stage 5 CKD and type 2 diabetes found that those on SGLT2 inhibitors had a substantially lower rate of progressing to end-stage kidney disease requiring dialysis compared to those not taking the drugs.18Scientific Reports. SGLT2 inhibitors reduce the risk of renal failure in CKD stage 5 patients with Type 2 DM Earlier evidence from trials like CREDENCE had already demonstrated effectiveness in people with diabetic kidney disease, reducing the risk of kidney failure and cardiovascular events.19PubMed Central. SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes For many patients, these medications can add months or even years before dialysis becomes necessary. If you have CKD and are not already on an SGLT2 inhibitor, it is worth asking your nephrologist whether one is appropriate for you.
Nutrition and the Wasting Problem
One factor that can push the dialysis start date earlier than expected is protein-energy wasting, a condition where the body breaks down its own muscle and fat stores. This is driven by a combination of toxin buildup, inflammation, and poor appetite. It becomes common once eGFR drops below about 45 and is closely tied to higher rates of illness and death in CKD patients, particularly those approaching or already on dialysis.20PubMed Central. Latest Consensus and Update on Protein Energy-Wasting in Chronic Kidney Disease If a patient is losing weight rapidly, their albumin levels are falling, and dietary interventions are not working, some nephrologists will lean toward starting dialysis even if the eGFR has not quite reached the traditional threshold. Dialysis can partially reverse wasting by removing some of the toxins that suppress appetite and drive muscle breakdown, though the evidence here is mixed and the response varies from person to person.
Children and Adolescents
The eGFR thresholds discussed so far apply to adults. For children, the picture is different in important ways. Pediatric kidneys are evaluated using a different equation (the bedside Schwartz formula rather than the adult CKD-EPI equation), and the eGFR at which dialysis begins varies widely. One large study of children and adolescents categorized patients by their eGFR at dialysis initiation into groups ranging from below 5 to above 12 mL/min/1.73 m².21PubMed. Estimated GFR at Dialysis Initiation and Mortality in Children and Adolescents Growth, nutritional status, and school participation all factor into the decision in ways that do not apply to adults. Pediatric nephrologists tend to weigh the impact of uremia on brain development and growth plates heavily, sometimes leaning toward earlier intervention if a child is falling off their growth curve even when the eGFR has not fallen to 15. A kidney transplant, rather than long-term dialysis, is the preferred outcome for most children, so dialysis in pediatric patients is often framed as a bridge to transplant rather than a long-term treatment.